Risk of Systemic Candida Infection in Immunocompromised Patients

Understanding the Relationship Between Osteomyelitis and Systemic Disease

Hematogenous dissemination is the primary mechanism by which Candida reaches bone, meaning the osteomyelitis itself is often evidence of prior systemic infection, particularly in immunocompromised patients with multiple bone involvement 1, 2
Multiple bone involvement occurs commonly in Candida osteomyelitis, and when a single focus is identified, clinicians must actively search for other sites of involvement, as this indicates disseminated disease 1, 2
The axial skeleton, especially the spine, is the most common site in adults, while long bones are more frequently involved in children 1

Immunocompromised status itself (neutropenia, chemotherapy, transplant, diabetes mellitus, chronic liver failure, chronic renal failure) dramatically increases risk of invasive Candida infections 3
Prolonged invasive vascular devices (hemodialysis catheters, central venous catheters) and total parenteral nutrition create portals for candidemia 3
Recent major surgery (particularly abdominal), necrotizing pancreatitis, and prolonged administration of broad-spectrum antibiotics increase susceptibility 3
Multisite colonization with Candida is a strong predictor, as clinical and molecular studies show that most Candida blood isolates are similar or identical to prior colonization in the patient's urinary and gastrointestinal tracts 4

When Candida osteomyelitis is diagnosed in an immunocompromised patient, a comprehensive search for disseminated infection is mandatory, including obtaining blood cultures immediately and repeating every 48-72 hours until clearance is documented 5, 6
Perform dilated ophthalmological examination within the first week of therapy in non-neutropenic patients to establish if endophthalmitis is present, particularly for patients with visual complaints or altered mental status 5, 6
For neutropenic patients, delay ophthalmologic examination until the first week after recovery from neutropenia 5, 6
Image kidneys, liver, and spleen if blood cultures remain persistently positive, as these are common sites of metastatic infection 7

Non-albicans Candida species are increasingly frequent causes of Candida osteomyelitis, and mixed infections with bacteria (especially Staphylococcus aureus) are not uncommon, underscoring the need for biopsy and culture 1, 2

Do not assume isolated bone infection without ruling out disseminated disease, as hematogenous spread is the dominant mechanism 1, 2
Do not delay systemic antifungal therapy while awaiting complete workup, as mortality increases with delayed treatment in immunocompromised patients 3
Do not overlook candiduria in neutropenic patients with persistent unexplained fever, as this may be a manifestation of disseminated candidiasis rather than simple colonization 4
Do not fail to remove central venous catheters when present, as catheter removal is strongly recommended for candidemia and improves outcomes 5, 6

Serial blood cultures should be obtained after 48-72 hours of antifungal therapy and then every other day to establish clearance 5, 6
Clinical deterioration, persistent fever, or new symptoms during therapy should prompt re-evaluation for additional sites of dissemination 1
Inflammatory markers (ESR, CRP) should be monitored to assess treatment response, although the strength of evidence for this recommendation is not provided 8